XML 26 R11.htm IDEA: XBRL DOCUMENT v3.19.3
Financial Instruments
9 Months Ended
Sep. 30, 2019
Financial Instruments  
Financial Instruments

5. Financial Instruments

The Company elected to invest a portion of its cash assets in conservative, income earning, and liquid investments. Cash equivalents and investments, all of which are classified as available-for-sale securities, consisted of the following:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30, 2019

 

December 31, 2018

 

 

    

Amortized
Cost

    

Gross
Unrealized
Gain

    

Gross
Unrealized
Loss

    

Estimated Fair Value

    

Amortized
Cost

    

Gross
Unrealized
Gain

    

Gross
Unrealized
Loss

    

Estimated Fair Value

 

 

 

(in thousands)

 

Money market deposits

 

$

5,666

 

$

 —

 

$

 —

 

$

5,666

 

$

26,539

 

$

 —

 

$

 —

 

$

26,539

 

U.S. Treasury securities

 

 

130,913

 

 

794

 

 

(72)

 

 

131,635

 

 

76,061

 

 

29

 

 

(405)

 

 

75,685

 

U.S. agency securities

 

 

7,000

 

 

 —

 

 

 —

 

 

7,000

 

 

13,017

 

 

 —

 

 

(126)

 

 

12,891

 

Municipal securities

 

 

47,928

 

 

161

 

 

(24)

 

 

48,065

 

 

18,935

 

 

 7

 

 

(57)

 

 

18,885

 

Total

 

$

191,507

 

$

955

 

$

(96)

 

$

192,366

 

$

134,552

 

$

36

 

$

(588)

 

$

134,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

$

5,666

 

 

 

 

 

 

 

 

 

 

$

26,539

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

186,700

 

 

 

 

 

 

 

 

 

 

 

107,461

 

Total

 

 

 

 

 

 

 

 

 

 

$

192,366

 

 

 

 

 

 

 

 

 

 

$

134,000

 

 

The Company invests in U.S. Treasuries, U.S. agency and high quality municipal bonds which mature at par value and are all paying their coupons on schedule. The Company has therefore concluded there is currently no other than temporary impairment of its investments and will continue to recognize unrealized gains and losses in other comprehensive income (loss). During the nine months ended September 30, 2019, there were no sales of investments, and during the nine months ended September 30, 2018, the amount of gross realized gains and realized losses upon sales of investments were insignificant. The Company uses the specific investment identification method to calculate realized gains and losses and amounts reclassified out of other comprehensive income to net income. As of September 30, 2019, the Company had 9 investments in an unrealized loss position in its portfolio.

The following table summarizes the Company’s portfolio of available-for-sale securities by contractual maturity as of September 30, 2019:

 

 

 

 

 

 

 

 

 

 

September 30, 2019

 

 

 

Amortized
Cost

 

Fair
Value

 

 

 

(in thousands)

 

Less than one year

 

$

86,161

 

$

86,343

 

Greater than one year but less than five years

 

 

99,680

 

 

100,357

 

Total

 

$

185,841

 

$

186,700